Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Clinical trial NCT02866175 · COMPLETED

Trial details

NCT number: NCT02866175
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2017-02-24
Primary completion: 2019-06-06
Enrollment: 1506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.